Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Analysis of clinical efficacy of Xuebijing injection in the treatment of ICU patients with severe community acquired pneumonia
Hits 1815  Download times 2484  Received:January 08, 2015  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2015.06.06
Key Words   Xuebijing injection;severe pneumonia;clinical effect
Author NameAffiliation
KONG Ling-yi ICU, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 
Abstract
    [Objective] To observe the clinical efficacy of Xuebijing injection in the treatment of severe community acquired pneumonia. [Methods] The selection of nearly two years of ICU in our hospital treated 68 cases of severe community acquired pneumonia in hospitalized patients, they are randomly divided into the observation group and control group, each group has 34 patients, all patients are in their drug sensitivity test is selected based on given antibiotics, patients in the control group conventional treatment methods of severe community acquired pneumonia, the observation group patients except the treatment methods, the use of Xuebijing injection. [Results] The clinical treatment of Xuebijing in the total effective rate of observation group is significantly higher than that in control group, APACHEII score, WBC, CRP and PCT index to improve the situation significantly better than the control group. [Conclusion] Xuebijing injection in the treatment of severe community acquired pneumonia has good clinical efficacy.

You are the 4033314 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.